Desenvolvimento e aplicação de eletrodos compósitos à base de grafite e Araldite® / Development and apllication of composite electrode graphite-Araldite®

AUTOR(ES)
DATA DE PUBLICAÇÃO

2008

RESUMO

The development and evaluation of the voltammetric behavior of composite electrodes prepared with graphite as a conducting phase and commercial epoxy resin Araldite ® as an insulating phase was performed. The resin was prepared according to instructions of the manufacturer and mixed with a suitable amount of graphite in order to prepare composites with 50, 60 and 70% of graphite (w/w). The composites were characterized in relation to their reproducibility of the cyclic voltammetric response, ohmic resistance, and repeatability of the effective area as a function of the Araldite ®/graphite ratio. The best repeatability of area as well as the higher peak currents was obtained with the 70% (graphite, w/w) composition using K3[Fe(CN)6] in KCl medium. The useful potential windows were also evaluated in different supporting electrolytes and pH ranges. Finally the composite electrodes were applied in the determination of the anti-hypertensive atenolol and the cathecolamine neurotransmitter dopamine. The composite electrodes were more sensitive to both analytes when compared to the glassy carbon. Dopamine was determined using differential pulse voltammetry (DPV) with linear dynamic range between 4.0 and 95 µmol L-1 and limit of detection 0.61 µmol L-1. The results agreed with those from high performance liquid chromatography (HPLC) within a 95% confidence interval. Atenolol was also determined by DPV with a 4.45 - 84.7 µmol L-1 linear range and 2.23 µmol L-1. The determination of atenolol in pharmaceutical formulations agreed with the HPLC method in a 95 % confidence interval. When applied to natural water samples spiked with the analyte, recoveries of 92 to 115% were found.

ASSUNTO(S)

pharmaceutical formulations composite electrode graphite-araldite® eletroanalytical techniques eletrodos compósitos de grafite-araldite® técnicas eletroanalíticas formulações farmacêuticas

ACESSO AO ARTIGO

Documentos Relacionados